These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Treatment of thyroid ophthalmopathy--a clinical case]. Andrei S; Zemba M; Zugravu V; Enache V; Renetti A; Spiroiu C Oftalmologia; 2007; 51(1):49-55. PubMed ID: 17605272 [TBL] [Abstract][Full Text] [Related]
25. Socioeconomic Disparities in the Presentation and Treatment of Graves' Disease and Thyroid Eye Disease. Vargason CW; Chelnis JG; Barahimi BI; Mawn LA Semin Ophthalmol; 2016; 31(4):409-14. PubMed ID: 27385363 [TBL] [Abstract][Full Text] [Related]
26. Orbital Radiation for Thyroid Eye Disease: A Report by the American Academy of Ophthalmology. Sobel RK; Aakalu VK; Vagefi MR; Foster JA; Tao JP; Freitag SK; Wladis EJ; McCulley TJ; Yen MT Ophthalmology; 2022 Apr; 129(4):450-455. PubMed ID: 34895729 [TBL] [Abstract][Full Text] [Related]
27. Severe Pediatric Thyroid Eye Disease: Surgical Case Series. Wu CY; Elner VM; Kahana A Ophthalmic Plast Reconstr Surg; 2017; 33(3S Suppl 1):S186-S188. PubMed ID: 26524159 [TBL] [Abstract][Full Text] [Related]
28. Thyroid eye disease: current and potential medical management. Pouso-Diz JM; Abalo-Lojo JM; Gonzalez F Int Ophthalmol; 2020 Apr; 40(4):1035-1048. PubMed ID: 31919775 [TBL] [Abstract][Full Text] [Related]
29. Interruption of autoimmunity for thyroid eye disease: B-cell and T-cell strategy. Strianese D; Rossi F Eye (Lond); 2019 Feb; 33(2):191-199. PubMed ID: 30610229 [TBL] [Abstract][Full Text] [Related]
30. Thyroid eye disease: therapy in the active phase. Bhatti MT; Dutton JJ J Neuroophthalmol; 2014 Jun; 34(2):186-97. PubMed ID: 24821102 [TBL] [Abstract][Full Text] [Related]
31. Contemporary diagnostic and therapeutic abilities in childhood thyroid-associated ophthalmopathy with a clinical case description. Kaleva NN; Pehlivanova NI; Misheva ZP; Shabanova TD; Balabanova AV Folia Med (Plovdiv); 2010; 52(2):57-63. PubMed ID: 20836398 [TBL] [Abstract][Full Text] [Related]
32. Recent advances in graves ophthalmopathy medical therapy: a comprehensive literature review. Li X; Li S; Fan W; Rokohl AC; Ju S; Ju X; Guo Y; Heindl LM Int Ophthalmol; 2023 Apr; 43(4):1437-1449. PubMed ID: 36272013 [TBL] [Abstract][Full Text] [Related]
34. A New Era in the Treatment of Thyroid Eye Disease. Patel A; Yang H; Douglas RS Am J Ophthalmol; 2019 Dec; 208():281-288. PubMed ID: 31377284 [TBL] [Abstract][Full Text] [Related]
36. A mild Grave's ophthalmopathy during pregnancy. Abbouda A; Trimboli P; Bruscolini A Semin Ophthalmol; 2014 Jan; 29(1):8-10. PubMed ID: 24171793 [TBL] [Abstract][Full Text] [Related]
37. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids]. Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418 [TBL] [Abstract][Full Text] [Related]
38. Retrobulbar 99mTc-diethylenetriamine-pentaacetic-acid uptake may predict the effectiveness of immunosuppressive therapy in Graves' ophthalmopathy. Ujhelyi B; Erdei A; Galuska L; Varga J; Szabados L; Balazs E; Bodor M; Cseke B; Karanyi Z; Leovey A; Mezosi E; Burman KD; Berta A; Nagy EV Thyroid; 2009 Apr; 19(4):375-80. PubMed ID: 19355827 [TBL] [Abstract][Full Text] [Related]
39. Evaluation and management of Graves' orbitopathy. Lee HB; Rodgers IR; Woog JJ Otolaryngol Clin North Am; 2006 Oct; 39(5):923-42, vi. PubMed ID: 16982255 [TBL] [Abstract][Full Text] [Related]